Skip to content
Search

Latest Stories

Sigma CEO Hatul Shah awarded fellowship by Royal Pharmaceutical Society

Sigma CEO Hatul Shah awarded fellowship by Royal Pharmaceutical Society

Names of 19 new RPS Fellows announced, along with a posthumous Fellowship

Hatul Shah, the CEO of Sigma Pharmaceuticals plc, has been elected as a Fellow of the Royal Pharmaceutical Society (RPS) for his exceptional services to the pharmacy industry.

Shah is one of the 19 distinguished members who were designated as Fellows for their significant contributions to the profession of pharmacy by the RPS Panel of Fellows on May 24.


Announcing the new RPS Fellows, the Royal Pharmaceutical Society highlighted that a Fellowship is one of the highest accolades that can be paid to a member as it “recognises the distinction members have attained in their pharmacy career.”

Expressing his gratitude upon receiving a Fellowship from the RPS, Shah wrote on LinkedIn: “I’m immensely proud to be honoured today with a Fellowship by the Royal Pharmaceutical Society for Services to the Pharmacy Industry.”

“I thank my peers who have nominated me to be selected amongst a select few but most of all thank my family, friends, Pharmacy partners, staff and of course all at Sigma - Independent Together group for their unwavering support throughout my career,”

“We continue to support the Pharmacy industry and always remain ‘Independent Together’!"

Hatul Shah graduated with a Master of Pharmacy from King’s College London in 2002 and pursued a career in Community Pharmacy immediately after his Pre-Registration. He furthered his education by earning an Executive MBA from Warwick Business School in 2018.

The RPS Panel of Fellows also recognised the following members for distinction in the pharmacy profession:

  1. Jeff Aston
  2. Sarah Cavanagh
  3. Richard Daniszewski
  4. Alastair Florence
  5. Benjamin Kelly Hannan
  6. Sundus Jawad
  7. Susan Catherine Jones
  8. Rupvinder Kahlon
  9. Emily Kennedy
  10. Stephen Morris
  11. Erutase Oputu
  12. Helen Porter
  13. Sobha Sharma Kandel
  14. Mathew Smith
  15. Nicola Stoner
  16. Judith Vincent
  17. Joseph Williams
  18. Laura Wilson

In addition, a posthumous Fellowship was awarded to Moody Meng, acknowledging his outstanding contributions to the pharmacy profession during his lifetime.

The Royal Pharmaceutical Society currently has 783 Fellows from various sectors and career stages within the profession.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less